HPV Assays With Pap Smears Could Safely Lengthen Screening Intervals
This article was originally published in The Gray Sheet
Use of human papillomavirus (HPV) DNA screening assays with conventional Pap smears could safely allow for women to wait longer intervals between cervical screenings, Jack Cuzick, PhD, noted in a Jan. 5 teleconference coinciding with the same-day publication of his editorial in the Journal of the American Medical Association.
You may also be interested in...
Foreign clinical data supporting human papilloma virus (HPV) testing as an adjunct to Pap smear in screening for cervical cancer need to be confirmed in U.S. studies, FDA's Microbiology Devices Panel recommended at its recent meeting in Gaithersburg, Maryland.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.